#

+1 (917) 893 7512

  • #
  • #
  • #
#

Global Bio CMO Market: Size, Trends & Forecasts (2018 Edition)

Publish Date:Oct 2018
No. of Pages:63

Format : Adobe Reader (PDF) Instant delivery

US$ 800.00

Scope of the Report

The report entitled “Global Bio CMO Market: Size, Trends & Forecasts (2018 Edition)”, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration rate, and manufacturing process. A brief segment analysis is provided with their actual and forecasted value. In addition, an analysis of the global biologics market by value, by top selling products, etc. is also mentioned in the report.

Growth of the overall global bio CMO market has been forecasted for the years 2018-2022, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Lonza Group, Boehringer Ingelheim, Samsung Biologics and Wuxi Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.

Company Coverage

Lonza Group
Boehringer Ingelheim
Samsung Biologics
Wuxi Biologics

Executive Summary

The pharmaceutical industry is a vital component of health care system globally and is mainly comprised of large number of private as well as public organizations that discover, develop, produce, and market drugs for medical use. World’s major pharmaceutical companies are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be categorized into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. These are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry. On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.

The global bio CMO market has shown upward trends over the past few years and is anticipated to follow the same trend in the coming years as well. The market is expected to rise at a significant growth rate over the forecasted period (2018-2022). Growth drivers, such as increase in pharmaceutical industry, potential biologics blockbusters, introduction of targeted therapins, grater outsourcing demand from global pharmas, etc. would help the market to grow.

1. Executive Summary

2. Introduction

2.1 Pharmaceutical Industry Overview
2.1.1 Segments of Pharmaceutical Industry (Drugs)
2.2 Biotechnology/Biologics Overview
2.3 Biosimilar Overview
2.4 Biologics/ Biosimilar Manufacturing
2.5 Bio CMO Overview
2.5.1 Comparison: In-House Vs CMO Production

3. Global Market Analysis

3.1 Global Biologics Market Analysis

3.1.1 Global Biologics Market by Value
3.1.2 Global Biologics Market by Top Selling Drugs

3.2 Global Biologics Manufacturing Market Analysis

3.2.1 Global Biologics Manufacturing Market by Value
3.2.2 Global Biologics Manufacturing Market by Segments (In-House, CMO)

3.3 Global Bio CMO Market Analysis

3.3.1 Global Bio CMO Market by Value
3.3.2 Global Bio CMO Market by Penetration Rate
3.3.3 Global Bio CMO Market by Capacity
3.3.4 Global Bio CMO Market by Manufacturing Processes (Downstream, Upstream, Fill and Finish)

3.4 Global Bio CMO Market Segment Analysis
3.4.1 Global Bio CMO Downstream Process Market by Value
3.4.2 Global Bio CMO Upstream Process Market by Value
3.4.3 Global Bio CMO Fill and Finish Process Market by Value

4. Competitive Landscape

4.1 Global Bio CMO Players by Capacity
4.2 Global Bio CMO Market Players Financial Comparison

5. Company Profiles

5.1 Lonza Group
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategy

5.2 Boehringer Ingelheim
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategy

5.3 Samsung Electronics (Samsung Biologics)
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategy

5.4 Wuxi Biologics
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategy
Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Global Biologics Market by Value; 2016-2017 (US$ Billion)
Figure 4: Global Biologics Market by Value; 2018-2022E (US$ Billion)
Figure 5: Global Biologics Manufacturing Market by Value; 2013-2017 (US$ Billion)
Figure 6: Global Biologics Manufacturing Market by Value; 2018-2022E (US$ Billion)
Figure 7: Global Biologics Manufacturing Market by Segments; 2017
Figure 8: Global Bio CMO Market by Value; 2013-2017 (US$ Billion)
Figure 9: Global Bio CMO Market by Value; 2018-2022E (US$ Billion)
Figure 10: Global Bio CMO Market by Penetration Rate; 2013-2017 (%)
Figure 11: Global Bio CMO Market by Penetration Rate; 2018-2022E (%)
Figure 12: Global Bio CMO Market by Capacity; 2014-2017 (KL)
Figure 13: Global Bio CMO Market by Capacity; 2018-2022E (KL)
Figure 14: Global Bio CMO Market by Manufacturing Processes; 2017
Figure 15: Global Bio CMO Downstream Process Market by Value; 2013-2017 (US$ Billion)
Figure 16: Global Bio CMO Downstream Process Market by Value; 2018-2022E (US$ Billion)
Figure 17: Global Bio CMO Upstream Process Market by Value; 2013-2017 (US$ Billion)
Figure 18: Global Bio CMO Upstream Process Market by Value; 2018-2022E (US$ Billion)
Figure 19: Global Bio CMO Fill and Finish Process Market by Value; 2013-2017 (US$ Billion)
Figure 20: Global Bio CMO Fill and Finish Process Market by Value; 2018-2022E (US$ Billion)
Figure 21: Global Bio CMO Players by Capacity; 2017
Figure 22: Lonza Group Sales; 2013-2017 (US$ Billion)
Figure 23: Lonza Group Sales by Geography; 2017
Figure 24: Lonza Group Sales by Segments; 2017
Figure 25: Boehringer Ingelheim Sales; 2013-2017 (US$ Billion)
Figure 26: Boehringer Ingelheim Sales by Segments; 2017
Figure 27: Boehringer Ingelheim Sales by Region; 2017
Figure 28: Samsung Electronics Segments Overview
Figure 29: Samsung Electronics Ownership Structure
Figure 30: Samsung Biologics Revenue; 2014-2017 (US$ Million)
Figure 31: Wuxi Biologics Revenue; 2014-2016 (US$ Million)
Figure 32: Wuxi Biologics Revenue by region; 2017
Figure 33: Wuxi Biologics Revenue by Services; 2017
Table 1: Chemical Drugs v/s 1st Generation Biologics v/s 2nd Generation Biologics
Table 2: US Approved Biosimilars
Table 3: Comparison: In-House Vs CMO Production
Table 4: Top Selling Biologic Drugs; 2017
Table 5: Global Bio CMO Market Players Financial Comparison